Drugs / Human cord blood mononuclear cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02952716 | Oct 2016 → Oct 2018 | carbon monoxide-induced delayed encephalopathy | Liaocheng People's Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human cord blood mononuclear cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02952716 ↗ |
| Modality | Cell therapy | “human cord blood mononuclear cell transplantation” NCT02952716 ↗ |